Bath & Body Works, Inc. (NYSE:BBWI) Shares Sold by Lecap Asset Management Ltd.

Lecap Asset Management Ltd. reduced its position in Bath & Body Works, Inc. (NYSE:BBWI - Free Report) by 38.5% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 74,284 shares of the company's stock after selling 46,579 shares during the quarter. Bath & Body Works accounts for approximately 0.8% of Lecap Asset Management Ltd.'s investment portfolio, making the stock its 25th largest holding. Lecap Asset Management Ltd.'s holdings in Bath & Body Works were worth $2,880,000 at the end of the most recent quarter.

A number of other hedge funds also recently added to or reduced their stakes in BBWI. FMR LLC boosted its position in Bath & Body Works by 17,496.5% during the third quarter. FMR LLC now owns 2,516,127 shares of the company's stock valued at $80,315,000 after purchasing an additional 2,501,828 shares in the last quarter. KBC Group NV boosted its holdings in shares of Bath & Body Works by 9,023.5% in the 3rd quarter. KBC Group NV now owns 1,701,813 shares of the company's stock valued at $54,322,000 after buying an additional 1,683,160 shares in the last quarter. Erste Asset Management GmbH bought a new stake in shares of Bath & Body Works in the 3rd quarter valued at about $50,483,000. Forest Avenue Capital Management LP grew its position in shares of Bath & Body Works by 19.1% in the 3rd quarter. Forest Avenue Capital Management LP now owns 1,467,763 shares of the company's stock worth $46,851,000 after buying an additional 235,173 shares during the last quarter. Finally, Verition Fund Management LLC raised its stake in shares of Bath & Body Works by 111.8% during the 3rd quarter. Verition Fund Management LLC now owns 1,345,777 shares of the company's stock worth $42,957,000 after acquiring an additional 710,333 shares in the last quarter. 95.14% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of analysts have recently weighed in on the company. Telsey Advisory Group reissued an "outperform" rating and issued a $42.00 price objective on shares of Bath & Body Works in a research report on Monday, November 25th. Argus reaffirmed a "hold" rating on shares of Bath & Body Works in a research report on Friday, January 10th. Wells Fargo & Company raised shares of Bath & Body Works from an "equal weight" rating to an "overweight" rating and boosted their target price for the stock from $42.00 to $48.00 in a research report on Friday, January 10th. Deutsche Bank Aktiengesellschaft raised their price target on shares of Bath & Body Works from $51.00 to $52.00 and gave the stock a "buy" rating in a report on Tuesday, November 26th. Finally, TD Cowen boosted their price objective on shares of Bath & Body Works from $42.00 to $48.00 and gave the company a "buy" rating in a report on Thursday, December 12th. One analyst has rated the stock with a sell rating, six have issued a hold rating and ten have assigned a buy rating to the company's stock. According to data from MarketBeat, Bath & Body Works has a consensus rating of "Moderate Buy" and a consensus price target of $43.19.

Bath & Body Works Price Performance

NYSE:BBWI traded down $0.17 during trading hours on Tuesday, reaching $35.31. The company had a trading volume of 2,200,104 shares, compared to its average volume of 2,959,165. The firm has a market cap of $7.65 billion, a PE ratio of 8.61, a price-to-earnings-growth ratio of 0.90 and a beta of 1.83. Bath & Body Works, Inc. has a 1-year low of $26.20 and a 1-year high of $52.99. The business's 50 day moving average price is $37.71 and its 200-day moving average price is $33.65.

Bath & Body Works (NYSE:BBWI - Get Free Report) last announced its quarterly earnings results on Monday, November 25th. The company reported $0.49 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.46 by $0.03. Bath & Body Works had a net margin of 12.43% and a negative return on equity of 44.03%. The firm had revenue of $1.61 billion for the quarter, compared to the consensus estimate of $1.58 billion. During the same period in the prior year, the firm posted $0.48 earnings per share. The firm's quarterly revenue was up 3.1% compared to the same quarter last year. On average, analysts expect that Bath & Body Works, Inc. will post 3.26 earnings per share for the current fiscal year.

Bath & Body Works Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, March 7th. Shareholders of record on Friday, February 21st will be given a dividend of $0.20 per share. The ex-dividend date of this dividend is Friday, February 21st. This represents a $0.80 dividend on an annualized basis and a yield of 2.27%. Bath & Body Works's dividend payout ratio is currently 19.51%.

About Bath & Body Works

Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.